Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:40 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableRecruitingINTERVENTIONAL

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

ClinicalTrials.gov · NCT06815939 · Registry updated: 2026-01-29

Condition / research focus: Human Papillomavirus (HPV); Cervical Intraepithelial Neoplasia; Uterine Cervical Neoplasms; Cervical Cancers
Sponsor: DL Analytics
Countries with listed sites: El Salvador
Registry dates and results: Start: 2025-02-12. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HPV Test (diagnostic_test)
EVA System (device)
Visual Inspection with Acetic Acid (VIA) (procedure)
Automated Visual Evaluation (AVE) (diagnostic_test) — also listed as: CINFinder
Image Capture with Mobile Phone (other)
Pregnancy test (diagnostic_test)
ScreenFire HPV test (diagnostic_test)
Colposcopy with biopsy (procedure)
Thermal Ablation (procedure)
Loop electrosurgical excision procedure (LEEP) (procedure)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Ministerio de Salud
San Salvador, El Salvador
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD

ClinicalTrials.gov · NCT03534934 · Registry updated: 2026-01-28

Condition / research focus: Pulmonary Disease, Chronic Obstructive; Osteoporosis
Sponsor: Punam K Saha
Countries with listed sites: United States
Registry dates and results: Start: 2019-02-26. Completion: 2025-03-19 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vital signs (diagnostic_test)
Urine Pregnancy Test (diagnostic_test)
Questionnaires (other)
Blood Test (diagnostic_test)
Duel-energy X-ray absorptiometry scan (diagnostic_test) — also listed as: DXA scan
Multi-detector computed tomography (diagnostic_test) — also listed as: MDCT, CT scan
Dual-energy X-ray absorptiometry scan (diagnostic_test) — also listed as: DXA scan

Where the study takes place — 2 listed sites

University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
Columbia University Medical Center
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA

ClinicalTrials.gov · NCT06781957 · Registry updated: 2026-01-26

Condition / research focus: OVARIAN STIMULATION; Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Canada
Registry dates and results: Start: 2024-09-15. Completion: 2026-01-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins Subcutaneos (drug)

Where the study takes place — 1 listed sites

Syneos Health
Québec, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1

ClinicalTrials.gov · NCT03845049 · Registry updated: 2026-01-26

Condition / research focus: Macular Telangiectasia
Sponsor: Centre Hospitalier Universitaire Dijon
Countries with listed sites: France
Registry dates and results: Start: 2019-07-03. Completion: 2025-03-26 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Inclusion examinations (other)
Aflibercept Injection [Eylea] (drug)
SHAM injection (drug)
Examinations during study (every month) (other)

Where the study takes place — 1 listed sites

CHU dijon Bourgogne
Dijon, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

PET Image in PAH Patients

ClinicalTrials.gov · NCT05452889 · Registry updated: 2026-01-21

Condition / research focus: Pulmonary Arterial Hypertension
Sponsor: Stephen Y. Chan
Countries with listed sites: United States
Registry dates and results: Start: 2022-07-11. Completion: 2027-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

18F-FGLN PET Imaging (diagnostic_test)
(18F)FPGLU (drug)

Where the study takes place — 1 listed sites

Montefiore Hospital Clinical and Translational Research Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy

ClinicalTrials.gov · NCT03877939 · Registry updated: 2026-01-13

Condition / research focus: Non-Viable Pregnancy
Sponsor: Vida Recoletas Sevilla
Countries with listed sites: Spain
Registry dates and results: Start: 2019-09-15. Completion: 2025-03-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood samples collection for analysis (diagnostic_test) — also listed as: Uterine biopsy sample collection (only in biochemical pregnancy patients)

Where the study takes place — 2 listed sites

IVI RMA Madrid
Madrid, Madrid, Spain
Site recruitment: Not reported
IVI RMA Seville
Seville, Seville, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Endoscopic Full Thickness Suturing of Mucosal, Submucosal and Perforation Defects Using Su2ura® GI System

ClinicalTrials.gov · NCT07315893 · Registry updated: 2026-01-07

Condition / research focus: Endoscopic Mucosal Resection; Endoscopic Submucosal Dissection (ESD)
Sponsor: Anchora Medical
Countries with listed sites: Israel
Registry dates and results: Start: 2025-08-18. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (9)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Su2ura® GI system (device)
Physical Examination (diagnostic_test)
Vital Signs (diagnostic_test)
Blood Test-Hematology (diagnostic_test)
Blood Test-Biochemistry (diagnostic_test)
Urine Pregnancy Test (diagnostic_test)
Gastroscopy (diagnostic_test)
Health-related quality of life (HR-QoL) (diagnostic_test)
Visual Analogue Scale (VAS) (diagnostic_test)

Where the study takes place — 1 listed sites

Tel-Aviv Sourasky Medical Center, Ichilov
Tel Aviv, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics

ClinicalTrials.gov · NCT04099823 · Registry updated: 2026-01-06

Condition / research focus: Hydrocephalus; Alzheimer Disease
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2019-10-31. Completion: 2027-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MRI screening form (other)
Urine pregnancy test (diagnostic_test)
MR brain (diagnostic_test)

Where the study takes place — 1 listed sites

Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment

ClinicalTrials.gov · NCT05080569 · Registry updated: 2025-12-31

Condition / research focus: Pregnancy Related; Fertility Issues; Luteal Phase Defect; Infertility Unexplained
Sponsor: UMC Utrecht
Countries with listed sites: Netherlands
Registry dates and results: Start: 2023-03-01. Completion: 2027-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Progesterone Vaginal Product (drug) — also listed as: Utrogestan
Placebo (drug)

Where the study takes place — 1 listed sites

UMC Utrecht
Utrecht, Netherlands
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

ICSI Versus Conventional IVF in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT07294027 · Registry updated: 2025-12-19

Condition / research focus: Unexplained Infertility
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Countries with listed sites: China
Registry dates and results: Start: 2026-01-01. Completion: 2028-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ICSI (procedure)
IVF (procedure)

Where the study takes place — 7 listed sites

Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Site recruitment: Not reported
Huangshi Central Hospital
Huangshi, Hubei, China
Site recruitment: Not reported
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Site recruitment: Not reported
Xiangyang Central Hospital
Xiangyang, Hubei, China
Site recruitment: Not reported
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Site recruitment: Not reported
Jiaxing Maternity and Child Health Care Hospital
Jiaxing, Zhejiang, China
Site recruitment: Not reported
Ningbo Women & Children's Hospital
Ningbo, Zhejiang, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias

ClinicalTrials.gov · NCT03135769 · Registry updated: 2025-12-19

Condition / research focus: Gestational Trophoblastic Neoplasias (GTN)
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2017-02-21. Completion: 2021-03-17 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Avelumab administration at 10mg/kg (drug)

Where the study takes place — 6 listed sites

Institut Bergonie
Bordeaux, France
Site recruitment: Not reported
Centre Francois Baclesse
Caen, France
Site recruitment: Not reported
Institut Paoli-Calmettes
Marseille, France
Site recruitment: Not reported
Aphp Hopital Tenon
Paris, France
Site recruitment: Not reported
Hospices Civils de Lyon - CHLS
Pierre-Bénite, France
Site recruitment: Not reported
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

ClinicalTrials.gov · NCT07269392 · Registry updated: 2025-12-16

Condition / research focus: In Vitro Fertilization (IVF); Embryo Transfer
Sponsor: National Taiwan University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-01. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial

ClinicalTrials.gov · NCT00854373 · Registry updated: 2025-12-12

Condition / research focus: Infertility
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2007-06-01. Completion: 2010-04-20 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bravelle(follicle stimulating hormone) (drug)
Saline ( placebo) (other)

Where the study takes place — 1 listed sites

UCSF- Mission Bay
San Francisco, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin

ClinicalTrials.gov · NCT05873725 · Registry updated: 2025-12-09

Condition / research focus: IVF; Infertility
Sponsor: Clinique Ovo
Countries with listed sites: Canada
Registry dates and results: Start: 2023-05-20. Completion: 2024-03-19 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follitropin delta (drug)

Where the study takes place — 1 listed sites

Clinique Ovo
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate

ClinicalTrials.gov · NCT03428165 · Registry updated: 2025-12-04

Condition / research focus: in Vitro Fertilization
Sponsor: Centre Hospitalier Universitaire de Nīmes
Countries with listed sites: France
Registry dates and results: Start: 2018-03-07. Completion: 2022-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG (other)

Where the study takes place — 2 listed sites

CHU Arnaud de Villeneuve
Montpellier, France
Site recruitment: Not reported
CHU Nimes
Nîmes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

ClinicalTrials.gov · NCT05169541 · Registry updated: 2025-11-24

Condition / research focus: Mannose-Binding Lectin Deficiency; Recurrent Pregnancy Loss; Recurrent Implantation Failure; Infertility; Habitual Abortion; Recurrent Miscarriage; Recurrent Spontaneous Abortion
Sponsor: Aalborg University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2016-01-01. Completion: 2026-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Aagaard Klinik
Aarhus, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Intravenous Immunoglobulin and Prednisolone for RPL After ART.

ClinicalTrials.gov · NCT04701034 · Registry updated: 2025-11-24

Condition / research focus: Habitual Abortion; Recurrent Pregnancy Loss; Fertility Disorders; Miscarriage
Sponsor: Aalborg University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2021-01-28. Completion: 2024-04-18 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring) (drug) — also listed as: IVIg
Prednisolone Tablets (drug)
Human Albumin Solution (drug) — also listed as: Albumin infusion
Placebo tablet (drug)

Where the study takes place — 1 listed sites

• The Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital
Aalborg, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

ClinicalTrials.gov · NCT05343572 · Registry updated: 2025-11-12

Condition / research focus: Asherman Syndrome; Atrophic Endometrium; Recurrent Implantation Failure
Sponsor: Hugh Taylor
Countries with listed sites: United States
Registry dates and results: Start: 2023-11-01. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Plerixafor (drug)

Where the study takes place — 1 listed sites

Yale Fertility Center
Orange, Connecticut, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Comparing the Effects of Oral Contraceptive Pills Versus Metformin

ClinicalTrials.gov · NCT03229057 · Registry updated: 2025-11-05

Condition / research focus: PCOS
Sponsor: Anuja Dokras
Countries with listed sites: United States
Registry dates and results: Start: 2018-01-15. Completion: 2024-07-15 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OCP + Metformin (drug)
OCP + Placebo (drug)
Metformin + Placebo (drug)

Where the study takes place — 2 listed sites

Penn State/ Hershey Medical Center
Hershey, Pennsylvania, United States
Site recruitment: Not reported
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

ClinicalTrials.gov · NCT06372119 · Registry updated: 2025-09-25

Condition / research focus: Embryo Transfer; Irregular Menstruation; Letrozole; Hormone Replacement Therapy
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2024-04-22. Completion: 2026-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole-stimulated cycle strategy (procedure) — also listed as: LETS
Artificial cycle strategy (procedure) — also listed as: AC

Where the study takes place — 2 listed sites

My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting
My Duc Phu Nhuan Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 18:40 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Not applicableRecruitingINTERVENTIONAL

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

ClinicalTrials.gov · NCT06815939 · Registry updated: 2026-01-29

Condition / research focus: Human Papillomavirus (HPV); Cervical Intraepithelial Neoplasia; Uterine Cervical Neoplasms; Cervical Cancers
Sponsor: DL Analytics
Countries with listed sites: El Salvador
Registry dates and results: Start: 2025-02-12. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (10)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HPV Test (diagnostic_test)
EVA System (device)
Visual Inspection with Acetic Acid (VIA) (procedure)
Automated Visual Evaluation (AVE) (diagnostic_test) — also listed as: CINFinder
Image Capture with Mobile Phone (other)
Pregnancy test (diagnostic_test)
ScreenFire HPV test (diagnostic_test)
Colposcopy with biopsy (procedure)
Thermal Ablation (procedure)
Loop electrosurgical excision procedure (LEEP) (procedure)

Where the study takes place — 1 listed sites

Ministerio de Salud
San Salvador, El Salvador
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

CT-Based Modeling of Bone Micro-Architecture and Fracture-Risk in COPD

ClinicalTrials.gov · NCT03534934 · Registry updated: 2026-01-28

Condition / research focus: Pulmonary Disease, Chronic Obstructive; Osteoporosis
Sponsor: Punam K Saha
Countries with listed sites: United States
Registry dates and results: Start: 2019-02-26. Completion: 2025-03-19 (may be estimated). No results posted in this registry response.

Products and interventions (7)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Vital signs (diagnostic_test)
Urine Pregnancy Test (diagnostic_test)
Questionnaires (other)
Blood Test (diagnostic_test)
Duel-energy X-ray absorptiometry scan (diagnostic_test) — also listed as: DXA scan
Multi-detector computed tomography (diagnostic_test) — also listed as: MDCT, CT scan
Dual-energy X-ray absorptiometry scan (diagnostic_test) — also listed as: DXA scan

Where the study takes place — 2 listed sites

University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
Site recruitment: Not reported
Columbia University Medical Center
New York, New York, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA

ClinicalTrials.gov · NCT06781957 · Registry updated: 2026-01-26

Condition / research focus: OVARIAN STIMULATION; Infertility
Sponsor: IBSA Institut Biochimique SA
Countries with listed sites: Canada
Registry dates and results: Start: 2024-09-15. Completion: 2026-01-13 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Gonadotropins Subcutaneos (drug)

Where the study takes place — 1 listed sites

Syneos Health
Québec, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3TerminatedINTERVENTIONAL

Comparative Multicenter Randomized Study of Aflibercept Versus Placebo in Macular Telangiectasia Type 1

ClinicalTrials.gov · NCT03845049 · Registry updated: 2026-01-26

Condition / research focus: Macular Telangiectasia
Sponsor: Centre Hospitalier Universitaire Dijon
Countries with listed sites: France
Registry dates and results: Start: 2019-07-03. Completion: 2025-03-26 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Inclusion examinations (other)
Aflibercept Injection [Eylea] (drug)
SHAM injection (drug)
Examinations during study (every month) (other)

Where the study takes place — 1 listed sites

CHU dijon Bourgogne
Dijon, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

PET Image in PAH Patients

ClinicalTrials.gov · NCT05452889 · Registry updated: 2026-01-21

Condition / research focus: Pulmonary Arterial Hypertension
Sponsor: Stephen Y. Chan
Countries with listed sites: United States
Registry dates and results: Start: 2022-07-11. Completion: 2027-02 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

18F-FGLN PET Imaging (diagnostic_test)
(18F)FPGLU (drug)

Where the study takes place — 1 listed sites

Montefiore Hospital Clinical and Translational Research Center
Pittsburgh, Pennsylvania, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Detection of Kisspeptins and miRNAs in Patients With Non-viable Pregnancy

ClinicalTrials.gov · NCT03877939 · Registry updated: 2026-01-13

Condition / research focus: Non-Viable Pregnancy
Sponsor: Vida Recoletas Sevilla
Countries with listed sites: Spain
Registry dates and results: Start: 2019-09-15. Completion: 2025-03-20 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Blood samples collection for analysis (diagnostic_test) — also listed as: Uterine biopsy sample collection (only in biochemical pregnancy patients)

Where the study takes place — 2 listed sites

IVI RMA Madrid
Madrid, Madrid, Spain
Site recruitment: Not reported
IVI RMA Seville
Seville, Seville, Spain
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Endoscopic Full Thickness Suturing of Mucosal, Submucosal and Perforation Defects Using Su2ura® GI System

ClinicalTrials.gov · NCT07315893 · Registry updated: 2026-01-07

Condition / research focus: Endoscopic Mucosal Resection; Endoscopic Submucosal Dissection (ESD)
Sponsor: Anchora Medical
Countries with listed sites: Israel
Registry dates and results: Start: 2025-08-18. Completion: 2026-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (9)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Su2ura® GI system (device)
Physical Examination (diagnostic_test)
Vital Signs (diagnostic_test)
Blood Test-Hematology (diagnostic_test)
Blood Test-Biochemistry (diagnostic_test)
Urine Pregnancy Test (diagnostic_test)
Gastroscopy (diagnostic_test)
Health-related quality of life (HR-QoL) (diagnostic_test)
Visual Analogue Scale (VAS) (diagnostic_test)

Where the study takes place — 1 listed sites

Tel-Aviv Sourasky Medical Center, Ichilov
Tel Aviv, Israel
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

MR Evaluation of Cerebrospinal Fluid (CSF) Dynamics

ClinicalTrials.gov · NCT04099823 · Registry updated: 2026-01-06

Condition / research focus: Hydrocephalus; Alzheimer Disease
Sponsor: Mayo Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2019-10-31. Completion: 2027-01 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

MRI screening form (other)
Urine pregnancy test (diagnostic_test)
MR brain (diagnostic_test)

Where the study takes place — 1 listed sites

Mayo Clinic
Rochester, Minnesota, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4RecruitingINTERVENTIONAL

Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment

ClinicalTrials.gov · NCT05080569 · Registry updated: 2025-12-31

Condition / research focus: Pregnancy Related; Fertility Issues; Luteal Phase Defect; Infertility Unexplained
Sponsor: UMC Utrecht
Countries with listed sites: Netherlands
Registry dates and results: Start: 2023-03-01. Completion: 2027-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Progesterone Vaginal Product (drug) — also listed as: Utrogestan
Placebo (drug)

Where the study takes place — 1 listed sites

UMC Utrecht
Utrecht, Netherlands
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Not applicableNot yet recruitingINTERVENTIONAL

ICSI Versus Conventional IVF in Couples With Unexplained Infertility

ClinicalTrials.gov · NCT07294027 · Registry updated: 2025-12-19

Condition / research focus: Unexplained Infertility
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Countries with listed sites: China
Registry dates and results: Start: 2026-01-01. Completion: 2028-07-30 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

ICSI (procedure)
IVF (procedure)

Where the study takes place — 7 listed sites

Beijing Obstetrics and Gynecology Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Site recruitment: Not reported
Huangshi Central Hospital
Huangshi, Hubei, China
Site recruitment: Not reported
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
Site recruitment: Not reported
Xiangyang Central Hospital
Xiangyang, Hubei, China
Site recruitment: Not reported
Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China
Site recruitment: Not reported
Jiaxing Maternity and Child Health Care Hospital
Jiaxing, Zhejiang, China
Site recruitment: Not reported
Ningbo Women & Children's Hospital
Ningbo, Zhejiang, China
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias

ClinicalTrials.gov · NCT03135769 · Registry updated: 2025-12-19

Condition / research focus: Gestational Trophoblastic Neoplasias (GTN)
Sponsor: Hospices Civils de Lyon
Countries with listed sites: France
Registry dates and results: Start: 2017-02-21. Completion: 2021-03-17 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Avelumab administration at 10mg/kg (drug)

Where the study takes place — 6 listed sites

Institut Bergonie
Bordeaux, France
Site recruitment: Not reported
Centre Francois Baclesse
Caen, France
Site recruitment: Not reported
Institut Paoli-Calmettes
Marseille, France
Site recruitment: Not reported
Aphp Hopital Tenon
Paris, France
Site recruitment: Not reported
Hospices Civils de Lyon - CHLS
Pierre-Bénite, France
Site recruitment: Not reported
Institut Universitaire Du Cancer de Toulouse - Oncopole
Toulouse, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4Not yet recruitingINTERVENTIONAL

Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

ClinicalTrials.gov · NCT07269392 · Registry updated: 2025-12-16

Condition / research focus: In Vitro Fertilization (IVF); Embryo Transfer
Sponsor: National Taiwan University Hospital
Countries with listed sites: No country reported
Registry dates and results: Start: 2026-01-01. Completion: 2029-12-31 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GnRH agonist (drug)

Where the study takes place — 0 listed sites

The registry does not list facilities in this record. This does not mean the study has no sites.

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Concomitant Administration of FSH With HCG Improves Oocyte Maturation and Quality Double -Blinded Randomized Trial

ClinicalTrials.gov · NCT00854373 · Registry updated: 2025-12-12

Condition / research focus: Infertility
Sponsor: University of California, San Francisco
Countries with listed sites: United States
Registry dates and results: Start: 2007-06-01. Completion: 2010-04-20 (may be estimated). Results are posted in this registry.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Bravelle(follicle stimulating hormone) (drug)
Saline ( placebo) (other)

Where the study takes place — 1 listed sites

UCSF- Mission Bay
San Francisco, California, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin

ClinicalTrials.gov · NCT05873725 · Registry updated: 2025-12-09

Condition / research focus: IVF; Infertility
Sponsor: Clinique Ovo
Countries with listed sites: Canada
Registry dates and results: Start: 2023-05-20. Completion: 2024-03-19 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Follitropin delta (drug)

Where the study takes place — 1 listed sites

Clinique Ovo
Montreal, Quebec, Canada
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Transfer of Frozen Embryos in Natural Cycle: Evaluation of Impact of Spontaneous Versus HCG-triggered Ovulation on Pregnancy Rate

ClinicalTrials.gov · NCT03428165 · Registry updated: 2025-12-04

Condition / research focus: in Vitro Fertilization
Sponsor: Centre Hospitalier Universitaire de Nīmes
Countries with listed sites: France
Registry dates and results: Start: 2018-03-07. Completion: 2022-02-01 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

HCG (other)

Where the study takes place — 2 listed sites

CHU Arnaud de Villeneuve
Montpellier, France
Site recruitment: Not reported
CHU Nimes
Nîmes, France
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableRecruitingOBSERVATIONAL

Association Between Plasma Level of Mannose Binding Lectin and Human Reproduction

ClinicalTrials.gov · NCT05169541 · Registry updated: 2025-11-24

Condition / research focus: Mannose-Binding Lectin Deficiency; Recurrent Pregnancy Loss; Recurrent Implantation Failure; Infertility; Habitual Abortion; Recurrent Miscarriage; Recurrent Spontaneous Abortion
Sponsor: Aalborg University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2016-01-01. Completion: 2026-11-30 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

Aagaard Klinik
Aarhus, Denmark
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 2CompletedINTERVENTIONAL

Intravenous Immunoglobulin and Prednisolone for RPL After ART.

ClinicalTrials.gov · NCT04701034 · Registry updated: 2025-11-24

Condition / research focus: Habitual Abortion; Recurrent Pregnancy Loss; Fertility Disorders; Miscarriage
Sponsor: Aalborg University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2021-01-28. Completion: 2024-04-18 (may be estimated). No results posted in this registry response.

Products and interventions (4)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring) (drug) — also listed as: IVIg
Prednisolone Tablets (drug)
Human Albumin Solution (drug) — also listed as: Albumin infusion
Placebo tablet (drug)

Where the study takes place — 1 listed sites

• The Centre for Recurrent Pregnancy Loss of Western Denmark, Department of Obstetrics and Gynaecology, Aalborg University Hospital
Aalborg, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Early Phase 1RecruitingINTERVENTIONAL

Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium

ClinicalTrials.gov · NCT05343572 · Registry updated: 2025-11-12

Condition / research focus: Asherman Syndrome; Atrophic Endometrium; Recurrent Implantation Failure
Sponsor: Hugh Taylor
Countries with listed sites: United States
Registry dates and results: Start: 2023-11-01. Completion: 2027-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Plerixafor (drug)

Where the study takes place — 1 listed sites

Yale Fertility Center
Orange, Connecticut, United States
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Comparing the Effects of Oral Contraceptive Pills Versus Metformin

ClinicalTrials.gov · NCT03229057 · Registry updated: 2025-11-05

Condition / research focus: PCOS
Sponsor: Anuja Dokras
Countries with listed sites: United States
Registry dates and results: Start: 2018-01-15. Completion: 2024-07-15 (may be estimated). Results are posted in this registry.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

OCP + Metformin (drug)
OCP + Placebo (drug)
Metformin + Placebo (drug)

Where the study takes place — 2 listed sites

Penn State/ Hershey Medical Center
Hershey, Pennsylvania, United States
Site recruitment: Not reported
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableRecruitingINTERVENTIONAL

Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

ClinicalTrials.gov · NCT06372119 · Registry updated: 2025-09-25

Condition / research focus: Embryo Transfer; Irregular Menstruation; Letrozole; Hormone Replacement Therapy
Sponsor: Mỹ Đức Hospital
Countries with listed sites: Vietnam
Registry dates and results: Start: 2024-04-22. Completion: 2026-04 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Letrozole-stimulated cycle strategy (procedure) — also listed as: LETS
Artificial cycle strategy (procedure) — also listed as: AC

Where the study takes place — 2 listed sites

My Duc Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting
My Duc Phu Nhuan Hospital
Ho Chi Minh City, Ho Chi Minh City, Vietnam
Site recruitment: Recruiting

Original record, eligibility, contacts and results →